<DOC>
	<DOCNO>NCT03096314</DOCNO>
	<brief_summary>This study aim evaluate effect early administration high-dose vitamin D3 reduce all-cause , all-location mortality vitamin D deficient patient high risk ARDS . Patients screen vitamin D deficiency ( &lt; 20 ng/mL ) . Only patient screen vitamin D deficient randomize . Half vitamin-D deficient patient give high-dose vitamin D3 half give placebo .</brief_summary>
	<brief_title>Vitamin D Improve Outcomes Leveraging Early Treatment</brief_title>
	<detailed_description>Primary Objective : To assess efficacy safety early administration vitamin D3 ( cholecalciferol ) reduce mortality morbidity vitamin D deficient patient high risk ARDS mortality . Primary Hypothesis : Early administration vitamin D3 ( cholecalciferol ) improve all-cause , all-location mortality day 90 vitamin D deficient patient high risk ARDS mortality . Patients recruit EDs , hospital ward , operate room , ICUs acute care area PETAL Network Clinical Centers . Screening include test Vitamin D ( 25OHD ) level use either hospital 's clinical laboratory FDA-approved point-of-care device ( FastPack IP , Qualigen Inc ) . Patients screen vitamin D deficient ( &lt; 20 ng/mL ) randomize . Half randomized patient receive early administration high-dose vitamin D3 half receive placebo ( orally via naso/orogastric tube ) . Vitamin D pleiotropic role regulate immune function maintain epithelial surface integrity . Strong preclinical data support protective role vitamin D regulating pulmonary inflammation disruption alveolar-capillary membrane fundamental ARDS pathogenesis .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Age â‰¥ 18 year 2 . Intention admit ICU emergency department , hospital ward , operate room , outside facility 3 . One follow acute risk factor ARDS mortality contribute directly need ICU admission : Pulmonary 1 . Pneumonia 2 . Aspiration 3 . Smoke Inhalation 4 . Lung contusion 5 . Mechanical ventilation acute hypoxemic hypercarbic respiratory failure ExtraPulmonary 6 . Shock 7 . Sepsis 8 . Pancreatitis 4 . Vitamin D deficiency ( screen 25OHD level &lt; 20 ng/mL ) 1 . Inability obtain informed consent 2 . Unable randomize within 12 hour ICU admission decision 3 . Unable take study medication mouth enteral tube 4 . Baseline serum calcium &gt; 10.2 mg/dL ( 2.54 mmol/L ) ionize calcium &gt; 5.2 mg/dL ( 1.30 mmol/L ) 5 . Known kidney stone past year history multiple ( &gt; 1 ) prior kidney stone episodes 6 . Decision withhold withdraw lifesustaining treatment ( patient still eligible commit full support except cardiopulmonary resuscitation cardiac arrest occur ) 7 . Expect &lt; 48 hour survival 8 . If risk factor present , ) mechanical ventilation primarily airway protection , pain/agitation control , procedure ; b ) elective surgical patient routine postoperative mechanical ventilation ; c ) anticipate mechanical ventilation duration &lt; 24 hour ; ) chronic/home mechanical ventilation chronic lung neuromuscular disease ( noninvasive ventilation use solely sleepdisordered breathe exclusion ) . 9 . Prisoner 10 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ARDS</keyword>
	<keyword>Vitamin D</keyword>
</DOC>